Result of GM and Total Voting Rights
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your GENI notes
GENinCode plc (AIM: GENI), the polygenics company focused on the prevention of cardiovascular disease ("CVD"), announces that all resolutions put to Shareholders at the General Meeting held earlier today in connection with the placing, subscription and retail offer announced by the Company on 21 December 2023 were duly passed.
| Resolution | For | Against | Withheld | Total votes cast | |||
|---|---|---|---|---|---|---|---|
| Number of votes | % | Number of votes | % | Number of votes | |||
| 1 | Ordinary resolution to authorise the directors to allot shares | 31,947,121 | 99.99% | 2,846 | 0.01% | 7,085 | 31,949,967 |
| 2 | Special resolution to authorise the directors to disapply pre-emption rights | 31,947,121 | 99.99% | 2,846 | 0.01% | 7,085 | 31,949,967 |
Issue of Equity and Total Voting Rights
Following shareholder approval at the general meeting and conditional on admission, 67,576,000 new ordinary shares have been allotted pursuant to the Placing, 1,147,560 new ordinary shares pursuant to the Retail Offer and 12,424,000 pursuant to the Subscription.
The Company has therefore allotted a total of 81,147,560 new ordinary shares in connection with the Fundraising.
Admission is expected to take place at 8.00 a.m. on or around 10 January 2024.
Following Admission, the total number of Ordinary Shares in the capital of the Company in issue will be 176,964,426 with each Ordinary Share carrying the right to one vote. There are no shares held in treasury and therefore, following Admission, the total number of voting rights in the Company will be 176,964,426.
Capitalised terms used in this announcement have the meaning given to them in the announcement of the Placing and Subscription dated 21 December 2023, unless otherwise defined in this announcement.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.